Nrc Health (NRC) EBIT Margin (2010 - 2026)

Nrc Health has disclosed EBIT Margin across 17 years of filings, most recently posting 9.15% for Q2 2026.

• In Q2 2026, EBIT Margin fell 1381.0% year-over-year to 9.15%; the TTM figure through Jun 2026 stood at 10.53% (down 924.0% YoY), while the FY2025 annual figure was 16.44%, down 816.0% from the prior year.
• EBIT Margin came in at 9.15% for Q2 2026 at Nrc Health, down from 16.0% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 32.09% in Q4 2022 to a low of 9.15% in Q2 2026.
• Average EBIT Margin over 5 years is 22.31%, with a median of 25.45% recorded in 2024.
• The largest YoY upside for EBIT Margin was 78 bps in 2025 against a maximum downside of 2065 bps in 2025.
• Over 5 years, EBIT Margin stood at 32.09% in 2022, then dropped by 4 bps to 30.81% in 2023, then slipped by 16 bps to 25.98% in 2024, then plunged by 49 bps to 13.27% in 2025, then plunged by 169 bps to 9.15% in 2026.
• Per Business Quant data, the three most recent EBIT Margin figures were 9.15% in Q2 2026, 16.0% in Q1 2026, and 13.27% in Q4 2025.